Thoracic epidural anesthesia improves outcome after breast surgery

Area of Science:

• Anesthesiology
• Surgical Oncology
• Pain Management

Background:

• General anesthesia is the standard for oncologic breast procedures.
• High thoracic epidural anesthesia was introduced for breast surgery in March 1993.
• This study compares outcomes between general anesthesia and thoracic epidural anesthesia.

Purpose of the Study:

• To compare outcomes of general anesthesia versus thoracic epidural anesthesia for oncologic breast procedures.
• Key outcomes include nausea, vomiting incidence, and time to discharge.
• Evaluate the safety and efficacy of thoracic epidural anesthesia in breast surgery.

Main Methods:

• Retrospective analysis of 136 oncologic breast procedures.
• Procedures performed by a single surgeon (T.J.E.) at Brigham and Women's Hospital.
• Chi-square analysis used to compare outcomes between anesthetic groups.

Main Results:

• Thoracic epidural anesthesia (TEA) showed significantly earlier hospital discharge (p=0.01).
• Post-quadrantectomy/axillary dissection, 51% of TEA patients discharged same day vs. 22% with general anesthesia (GA).
• Nausea/vomiting incidence was significantly lower with TEA (20%) vs. GA (56%) (p=0.002).

Conclusions:

• Thoracic epidural anesthesia is a safe technique for breast surgery.
• No neurologic or respiratory complications were associated with TEA.
• TEA may improve patient recovery and reduce healthcare costs for breast procedures.